Respiratory infections Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Respiratory infections clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 1Phase 2

A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection

Cystic Fibrosis LungRespiratory Infections, Recurrent, Chronic
Respirion Pharmaceuticals Pty Ltd72 enrolled22 locationsNCT06016088
Recruiting

The Fever Clinic Acute Respiratory Cohort

Community-acquired PneumoniaFebrile IllnessesViral Respiratory Tract Infections+1 more
Fudan University1,000 enrolled1 locationNCT07278700
Recruiting
Not Applicable

Efficacy of Ultraviolet Germicidal Irradiation Devices to Reduce Respiratory Infections in Nursing Homes: Cluster Randomized Crossover Trial

Acute Respiratory Infections
Centre Hospitalier Emile Roux1,200 enrolled12 locationsNCT06569160
Recruiting

FebriDx® Pediatric Validation Study

Acute Respiratory Infections (ARIs)
Lumos Diagnostics800 enrolled10 locationsNCT07211997
Recruiting

Impact of the Presence of Anti-interferon Autoantibodies on the Viral Load in Severe Respiratory Infections

Severe Respiratory Infections
Hospices Civils de Lyon360 enrolled3 locationsNCT05536219
Recruiting

Negative predictive value of the FebriDx host response point-of-care test in patients presenting to a single Australian Emergency Department with suspected COVID-19.

COVID-19InfectionAcute Respiratory Infections
Planet Innovation300 enrolled1 locationACTRN12620001029987
Recruiting

A Clinical Registry for Children presenting to Hospital with Respiratory Infections.

Acute Respiratory Infection/ Respiratory InfectionsInfectious Diseases
Telethon Kids Institute4,000 enrolled1 locationACTRN12619000903189
Recruiting

Online decision support system for consumer health

Uptake of influenza vaccination (annual seasonal or H1N1) over the respiratory infections season (i.e. winter season)
The HCF Health and Medical Research Foundation600 enrolled1 locationACTRN12610000386033